[NBIX] QoQ Quarter Result on 30-Sep-2012 [#Q3]

Stock
[NBIX] Neurocrine Biosciences, Inc.
Announcement Date
31-Oct-2012
Financial Year
2012
Quarter
30-Sep-2012 [#Q3]
Profit Trend
QoQ- -514.37%
YoY- -109.81%
Quarter Report
NBIX's Result
NBIX's Financial Summary
View:
Show?
Quarter Result
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Revenue 730 730 21,947 9,357 10,569 11,267 11,110 -83.74%
PBT -12,242 -12,075 9,490 -3,078 -501 -886 1,331 -
Tax -1,093 -898 -1,079 -884 -879 -906 -884 15.21%
NP -12,242 -12,075 9,490 -3,078 -501 -886 1,331 -
Tax Rate - - 11.37% - - - 66.42% -
Total Cost 12,972 12,805 12,457 12,435 11,070 12,153 9,779 20.74%
Ratio Analysis
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
NP Margin -1,676.99 -1,654.11 43.24 -32.90 -4.74 -7.86 11.98 -
Per Share
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
EPS -0.18 -0.18 0.14 -0.05 -0.01 -0.01 0.02 -
EPS Diluted -0.18 -0.18 0.14 -0.05 -0.01 -0.01 0.02 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.